SCORE2 an updated algorithm tailored to European populations to predict 10-year risk of first-onset CVD. By updating SCORE in several aspects, the use of SCORE2 will enhance the identification of individuals at higher risk of developing CVD across Europe.
It is the first large, population based study to investigate the association of the combined effects of air pollution and changes in PA with CVD in young adults aged 20– 39 years.
A trial tested for the first time the effects of group metacognitive therapy on anxiety and depressive symptoms when delivered alongside cardiac rehabilitation (CR).
The American Diabetes Association’s 81st Annual Scientific Sessions was the biggest diabetes conference of the year took place virtually for the second year in a row. The annual meeting brought together researchers, healthcare providers, diabetes technology companies, and many more from around the globe. There were more than 1,400 original research presentations and over 180 sessions on the latest advancements in research, treatment, and care for people with diabetes.
The American Diabetes Association’s 81st Annual Scientific Sessions was the biggest diabetes conference of the year took place virtually for the second year in a row. The annual meeting brought together researchers, healthcare providers, diabetes technology companies, and many more from around the globe. There were more than 1,400 original research presentations and over 180 sessions on the latest advancements in research, treatment, and care for people with diabetes.
